{"id":3574,"date":"2013-07-09T15:14:26","date_gmt":"2013-07-09T06:14:26","guid":{"rendered":"https:\/\/www.peptide.co.jp\/en\/?page_id=3574"},"modified":"2023-11-14T17:24:18","modified_gmt":"2023-11-14T08:24:18","slug":"amyloid-beta-protein","status":"publish","type":"page","link":"https:\/\/www.peptide.co.jp\/en\/support\/useful\/amyloid-beta-protein","title":{"rendered":"List of Amyloid \u03b2-Protein and Related Products"},"content":{"rendered":"

Amyloid \u03b2-Protein Fragments<\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Code<\/th>\nCompound<\/th>\nPackage<\/th>\n<\/tr>\n
4307-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-40)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4379-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-40) [HCl Form]<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4349-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-42)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4370-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-43)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4359-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-16)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4481-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-28)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4484-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-38)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4492-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 11-40)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4493-v<\/a><\/td>\n[Pyr11<\/sup>]-Amyloid \u03b2-Protein (Human, 11-40)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4309-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 25-35)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4367-v<\/a><\/td>\n[Pyr3<\/sup>]-Amyloid \u03b2-Protein (Human, 3-42)<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4358-v<\/a><\/td>\n\u03b2-Sheet Breaker Peptide iA\u03b25<\/a><\/td>\n5 mg vial<\/td>\n<\/tr>\n
AF-683<\/a><\/td>\nAmyloid \u03b2-Protein (1-42, O<\/i>-acyl isopeptide)<\/a><\/td>\n2 mg bulk<\/td>\n<\/tr>\n
4518-v<\/a><\/td>\nAPP669-711<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Amyloid \u03b2-Protein Control Peptides<\/h3>\n\n\n\n\n\n\n\n
Code<\/th>\nCompound<\/th>\nPackage<\/th>\n<\/tr>\n
4413-s<\/a><\/td>\nAmyloid \u03b2-Protein (40-1)<\/a><\/td>\n0.1 mg vial<\/td>\n<\/tr>\n
4420-s<\/a><\/td>\nAmyloid \u03b2-Protein (42-1)<\/a><\/td>\n0.1 mg vial<\/td>\n<\/tr>\n
4513-s<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-40) (Scrambled)<\/a><\/td>\n0.1 mg vial<\/td>\n<\/tr>\n
4514-s<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-42) (Scrambled)<\/a><\/td>\n0.1 mg vial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Neuronal Protectant against Toxic A\u03b242 Oligomers<\/h3>\n\n\n\n\n\n
Code<\/th>\nCompound<\/th>\nPackage<\/th>\n<\/tr>\n
4485-v<\/a><\/td>\np3-Alc\u03b237<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n
4510-v<\/a><\/td>\np3-Alc\u03b29-19<\/a><\/td>\n0.5 mg vial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u03b2-Secretase Inhibitor<\/h3>\n\n\n\n\n
Code<\/th>\nCompound<\/th>\nPackage<\/th>\n<\/tr>\n
4378-v<\/a><\/td>\nLys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Sta-Val-Ala-Glu-Phe<\/a><\/td>\n1 mg vial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u03b2-Secretase Substrate<\/h3>\n\n\n\n\n
Code<\/th>\nCompound<\/th>\nPackage<\/th>\n<\/tr>\n
3212-v<\/a><\/td>\nMOCAc-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg-NH2<\/sub><\/a><\/td>\n1 mg vial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u03b3-Secretase Inhibitors<\/h3>\n\n\n\n\n\n
Code<\/th>\nCompound<\/th>\nPackage<\/th>\n<\/tr>\n
4394-v<\/a><\/td>\nL-685,458<\/a><\/td>\n1 mg vial<\/td>\n<\/tr>\n
3219-v<\/a><\/td>\n(3,5-Difluorophenylacetyl)-Ala-Phg-OBut (DAPT)<\/a><\/td>\n5 mg vial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u03b3-Secretase Substrate<\/h3>\n\n\n\n\n
Code<\/th>\nCompound<\/th>\nPackage<\/th>\n<\/tr>\n
3217-v<\/a><\/td>\nNma-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Lys(Dnp)-D<\/span>-Arg-D<\/span>-Arg-D<\/span>-Arg-NH2<\/sub><\/a><\/td>\n1 mg vial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Antisera<\/h3>\n\n\n\n\n\n\n\n\n
Code<\/th>\nCompound<\/th>\nPackage<\/th>\n<\/tr>\n
14359-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-16) Antiserum<\/a><\/td>\n50 \u03bcl vial<\/td>\n<\/tr>\n
14307-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 1-40) Antiserum<\/a><\/td>\n50 \u03bcl vial<\/td>\n<\/tr>\n
14356-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 34-40) Antiserum<\/a><\/td>\n50 \u03bcl vial<\/td>\n<\/tr>\n
14357-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 37-42) Antiserum<\/a><\/td>\n50 \u03bcl vial<\/td>\n<\/tr>\n
14414-v<\/a><\/td>\nAmyloid \u03b2-Protein (Human, 37-43) Antiserum<\/a><\/td>\n50 \u03bcl vial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Amyloid \u03b2-Protein Fragments Code Compound Package 4307-v Amyloid \u03b2-Protein (Human, 1-40) 0.5 mg vial 4379-v Am […]<\/p>\n","protected":false},"author":1,"featured_media":996,"parent":100,"menu_order":433,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages\/3574"}],"collection":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/comments?post=3574"}],"version-history":[{"count":16,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages\/3574\/revisions"}],"predecessor-version":[{"id":5090,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages\/3574\/revisions\/5090"}],"up":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages\/100"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/media\/996"}],"wp:attachment":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/media?parent=3574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}